Prevalence and risk factors for cataracts in the Lao People's Democratic Republic: The Vientiane Eye Study.
Cataracts
Lao
prevalence
risk factors
Journal
Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
entrez:
3
5
2022
pubmed:
4
5
2022
medline:
6
5
2022
Statut:
ppublish
Résumé
To determine the prevalence and risk factors for cataracts in the Vientiane Province. We conducted a population-based study of 1264 participants aged ≥40 years of age from urban and rural areas of Vientiane Province. Data collection included demographic information, smoking history, body mass index, blood pressure, history of trauma and dilated lens examination using the World Health Organization WHO Simplified Cataract Grading System. Aphakic and pseudophakic eyes were included as operated cataracts for statistical analysis. The mean age of the 1264 participants was 57.6 years. The prevalence of any cataract including operated eyes was 46.8% (95% CI: 44.1 - 49.6%): 36.9% nuclear, 21.7% cortical and 10.1% posterior subcapsular cataracts. The prevalence of cataract in the Vientiane Eye Study is similar compared to the prevalence reported in other studies from Asian regions; however, the median age in this study was low, reflecting the age group of the population and the rapid urbanisation occurring in the Lao People's Democratic Republic. A significant association for any cataract was found with elevated blood pressure >148mmHg (OR2.48, 95%CI:1.55 - 3.97, P < 0.01), increasing age (OR1.19, 95%CI:1.17 - 1.22, P < 0.001) and rural inhabitants for cortical cataract (OR1.99, 95%CI:1.37 - 2.90, P < 0.001). An inverse relationship between rural inhabitants with any cataract and nuclear cataract was found (OR 0.63, 95%CI: 0.45 - 0.89, P < 0.01 and OR 0.42, 95%CI: 0.31 - 0.59, P < 0.001) respectively. Nevertheless, cataract remains a high prevalence disease in this population.
Identifiants
pubmed: 35502034
pii: IndianJOphthalmol_2022_70_5_1599_343955
doi: 10.4103/ijo.IJO_2137_21
pmc: PMC9332997
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1599-1605Commentaires et corrections
Type : CommentIn
Déclaration de conflit d'intérêts
None
Références
Br J Ophthalmol. 2020 Feb;104(2):220-224
pubmed: 31221669
Ophthalmic Epidemiol. 2010 Jan-Feb;17(1):34-40
pubmed: 20100098
Invest Ophthalmol Vis Sci. 2016 Mar;57(3):1193-200
pubmed: 26975031
Br J Ophthalmol. 2008 Sep;92(9):1169-74
pubmed: 18650216
PLoS One. 2015 Aug 18;10(8):e0135870
pubmed: 26284359
Am J Epidemiol. 2000 Mar 1;151(5):497-504
pubmed: 10707918
PLoS One. 2014 Dec 11;9(12):e114245
pubmed: 25502762
Invest Ophthalmol Vis Sci. 2012 Jun 22;53(7):3885-95
pubmed: 22599585
PLoS One. 2014 Jun 17;9(6):e96461
pubmed: 24936893
BMC Ophthalmol. 2014 Jul 24;14:94
pubmed: 25060855
Lancet Glob Health. 2021 Feb;9(2):e144-e160
pubmed: 33275949
Br J Ophthalmol. 2019 Jul;103(7):878-884
pubmed: 30209084
Ophthalmic Epidemiol. 2002 Apr;9(2):83-95
pubmed: 11821974
Ophthalmology. 2011 Nov;118(11):2113-9
pubmed: 21684602
PLoS One. 2014 Feb 24;9(2):e89923
pubmed: 24587127
Ophthalmology. 2002 Nov;109(11):2058-64
pubmed: 12414415
Br J Ophthalmol. 2022 Aug;106(8):1121-1125
pubmed: 33737304
PLoS One. 2014 Dec 04;9(12):e114012
pubmed: 25474403
Br J Ophthalmol. 2004 Aug;88(8):989-94
pubmed: 15258010
Eye (Lond). 2015 Jul;29(7):913-20
pubmed: 25976646
Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):203-12
pubmed: 22527317
Nippon Ganka Gakkai Zasshi. 1995 Feb;99(2):204-11
pubmed: 7701993